Pressure BioSciences, Inc. Share Price Other OTC
Equities
PBIO
US74112E2081
Medical Equipment, Supplies & Distribution
Sales 2021 | 2M 167M | Sales 2022 | 1.73M 144M | Capitalization | 15.89M 1.33B |
---|---|---|---|---|---|
Net income 2021 | -20M -1.67B | Net income 2022 | -16M -1.34B | EV / Sales 2021 | 16.4 x |
Net Debt 2021 | 14.51M 1.21B | Net Debt 2022 | 20.53M 1.71B | EV / Sales 2022 | 21.1 x |
P/E ratio 2021 |
-0.68
x | P/E ratio 2022 |
-0.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.82% |
Latest transcript on Pressure BioSciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 01/78/01 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 24/06/24 |
Chief Tech/Sci/R&D Officer | 59 | 03/06/03 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 01/78/01 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 03/12/03 |
Michael Urdea
BRD | Director/Board Member | 71 | 08/13/08 |
1st Jan change | Capi. | |
---|---|---|
-5.51% | 182B | |
+2.33% | 111B | |
-3.62% | 68.48B | |
+1.52% | 49.69B | |
+8.06% | 44.46B | |
+2.33% | 40.67B | |
+23.35% | 31.22B | |
+0.67% | 26.09B | |
+15.30% | 25.32B |